| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 197 |
| 1 | FUROSEMIDE | 120 |
| 2 | ASPIRIN | 113 |
| 3 | ASPIRIN 325 MG | 98 |
| 4 | ASPIRIN 81 MG | 98 |
| 5 | WARFARIN | 71 |
| 6 | APIXABAN | 70 |
| 7 | CLOPIDOGREL | 61 |
| 8 | CLOPIDOGREL BISULFATE | 59 |
| 9 | METOPROLOL TARTRATE | 49 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FONDAPARINUX SODIUM | 30 | 0.0037 |
| 1 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 4 | 0.0036 |
| 2 | COAGULATION FACTOR VIIA (RECOMBINANT) | 9 | 0.0033 |
| 3 | ETELCALCETIDE | 8 | 0.0028 |
| 4 | EPINASTINE HYDROCHLORIDE | 3 | 0.0026 |
| 5 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 20 | 0.0024 |
| 6 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 9 | 0.0020 |
| 7 | DALTEPARIN SODIUM | 19 | 0.0018 |
| 8 | ALTEPLASE | 26 | 0.0017 |
| 9 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 5 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 264 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 165 |
| 2 | Loop Diuretic [EPC] | 125 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 118 |
| 4 | Corticosteroid [EPC] | 111 |
| 5 | Proton Pump Inhibitor [EPC] | 70 |
| 6 | P2Y12 Platelet Inhibitor [EPC] | 59 |
| 7 | Benzodiazepine [EPC] | 51 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 51 |
| 9 | Kinase Inhibitor [EPC] | 50 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 3 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 4 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 5 | Phosphodiesterase 3 Inhibitor [EPC] | 6 | 0.0010 |
| 6 | Factor Xa Inhibitor [EPC] | 264 | 0.0010 |
| 7 | Gadolinium-based Contrast Agent [EPC] | 4 | 0.0008 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 9 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |